MiR-29b replacement inhibits proteasomes and disrupts aggresome+autophagosome formation to enhance the antimyeloma benefit of bortezomibSajjeev Jagannathan, James J. Driscoll|Leukemia|2014Cited by 78
IRF2 is a master regulator of human keratinocyte stem cell fateNicolas Mercado, Susan C. Kirkland, Christian Kolter et al.|Nature Communications|2019Cited by 38